Don Busiek

Corporate Strategy, PTC

Don Busiek is the Senior Vice President of Corporate Strategy at PTC, where he helps to define a differentiating and sustainable strategy for one of the world’s most innovative companies. He came to PTC from General Electric where he was the General Manager of the Manufacturing Software business. Prior to that he served as the Program Director of Strategy and Product Management for the Maximo business unit at both IBM and, prior to being acquired, also at MRO Software. Don believes passionately in delivering high quality solutions to market and that the Internet of Things can change the world. Don has more than 20 years of technology experience in positions ranging from IT to Development to Professional Services. He holds an undergraduate degree from Hamilton College and graduated Magna Cum Laude with his MBA from Babson College. He is married with three beautiful daughters, Skylar, Avery and Dempsey.

Session Details

Monday, June 18 1:30 PM - 2:15 PM 204 B

s711 - Exploring Augmented Reality to Enhance Language & Learning for Persons with Autism: A PTC and Boston Children’s Hospital Project

One in 88 children has some form of autism spectrum disorder (ASD). Children with autism often have difficulty understanding written or spoken language, but show extreme interest in electronic screen media. By its very nature, Augmented Reality serves as a bridge between the physical and digital worlds by overlaying images onto a physical environment. Could Augmented Reality help those with autism learn by connecting these two worlds? This hypothesis is currently under test in a pioneering project of PTC and Boston Children’s Hospital. The project is led by Dr. Howard Shane, the Director of the Center for Communication Enhancement at Boston Children’s Hospital and Associate Professor of Otology and Laryngology at Harvard Medical School, in collaboration with a team of PTC volunteers. This presentation will introduce the work of Boston Children’s Hospital in serving children on the Autism Spectrum. We’ll explain how the project was launched and organized, review the current hypothesis under test, and demo a prototype that is being evaluated for clinical effectiveness. Finally, we’ll brainstorm on a range of potential uses for AR to transform the treatment of autism spectrum disorders.

Learn More